Command Palette

Search for a command to run...

AJANTPHARM
2610.7(+2.81%)
1W: +6.04%

Ajanta Pharma Quarterly Results

Charts

YoY Net Sales (Quarterly)
Operating Margin
EPS Growth

Pros & Cons

POSITIVES
  • Revenue growth of 15.4% YoY in the latest quarter indicates strong demand.
  • Profit margins improved to 20.44%, suggesting better cost management.
  • Operating profit increased significantly by 20.8% in the latest quarter.
NEGATIVES
  • Expense growth of 12.6% in the last quarter outpaced revenue growth.
  • Net profit declined by 8.9% compared to the previous quarter.
  • Other income dropped significantly, impacting overall profitability.

Quarterly Results Data (Numbers are in Crore)

FieldTrendJun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25
Revenue
1,021.041,028.441,105.151,054.081,144.921,186.641,146.131,170.411,302.651,353.73
Expenses
749.72737.78791.08775.76814.57875.47825.30873.26951.301,025.90
Operating Profit
271.32290.66314.07278.32330.35311.17320.83297.15351.35327.83
Other Income
31.7521.3313.5935.5026.4719.4830.4418.1126.3359.34
Interest
0.852.342.491.530.736.027.916.075.263.39
Depreciation
33.1833.7134.2634.2533.9734.3935.9739.7841.2942.97
Profit Before Tax
269.04275.94290.91278.04322.12290.24307.39269.41331.13340.81
Tax
60.9280.6480.8875.3276.3573.7674.5144.1575.7980.62
Net Profit
208.12195.30210.03202.72245.77216.48232.88225.26255.34260.19
Eps in Rs
16.5315.5116.6816.1019.5417.2718.601820.4420.83

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.